As the field continues to advance, integrating genetic information into treatment strategies will be essential for improving outcomes and developing targeted therapies for Alzheimer’s ... May 08
Digital biomarker startup Koneksa has raised $45 million in their Series C funding round.... Feb 08
Latest Pharma news update... Aug 13
Facts about the Alzheimer's disease... Jul 08
Lecanemab is indicated for the treatment of Alzheimer’s Disease... Jun 26
FDA shows hope to Alzheimer’s Disease patients this year. The drug Aduhelm may provide a sigh of relief to the patients suffering from Alzheimer’... Jun 09
Collab for research... May 17
To date, Sputnik V has been registered in 61 countries globally covering a total population of over 3 billion people.... Apr 23
... Mar 26
GlymaxX enables a boost of antibody-dependent cell-mediated cytotoxicity (ADCC)... Mar 18
Polaryx Therapeutics, today announced that it has received from the U.S. Food and Drug Administration (FDA) both Rare Pediatric Disease and Orphan Drug Designations ... Dec 18
Today, Biogen and Eisai, Co., Ltd. announced that Biogen has submitted a Japanese New Drug Application (J-NDA) to the Ministry of Health, Labor and ... Dec 10
ISD and Biogen will work together to develop ISD's lead compound, ISD 017, which is being developed to treat severe lupus - systemic lupus erythematosus (... Nov 24
Public Citizen's Health Research Group said that the FDA should not approve aducanumab for treatment of Alzheimer's disease due to lack of evidence ... Nov 07
Invitae and Pacific Biosciences collaborate to develop whole genome sequencing-based assays for pediatric epilepsy diagnostics ... Oct 23
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the U.S. FDA for Dimethyl Fumarate DR Capsules, the generic version of Tecfidera... Oct 07
After Dr Reddy's, Lupin Ltd. also launches Dimethyl Fumarate Delayed-Release Capsules... Oct 06
Cipla Limited today announced that it has received final approval for its ANDA for Dimethyl Fumarate Capsules... Sep 25
ACTO cements its position as the largest life sciences commercial learning and development platform ... Sep 15
The FDA now has up to 60 days to decide whether to accept the application for review... Jul 09
Roche's spinal muscular atrophy (SMA) drug risdiplam hit another clinical trial target, the Swiss drugmaker said on Thursday, which analysts said bolsters its prospects ... Jan 24
Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the appointment of Jay Stella as Chief Business Officer... Dec 18
Samsung Bioepis’ BRENZYS™ (etanercept) becomes available in Brazil through Brazil’s public health system, Sistema Único de Saúde (SUS) Established seven years ago, Samsung ... Sep 11
-Advertisements-
Thursday, May 16, 2024
